Yes, it is the ATCOR Pulse :
Our launch date for the Pulse remains on track and we’ve already received the first prototypes and test
units in our US and Sydney offices. Our first contracted order of the Pulse will be ~10,000 units. As a
guide to the impact of this new device on the revenues for the Company, our current device sales of
the XCEL central blood pressure monitor (which constitutes the most significant portion of our sales)
are in the low hundreds annually
A reminder from the ASX release about Andon and Atcor Pulse :
The first device under the Agreement to be named ATCOR “Pulse” (the Device) and will be
targeted for commercial launch in the US, Europe, Australia and China in Q4 2021.
ATCOR “Pulse” will be the first new medical device for ATCOR since 2012 and represents a
game changing medical technology collaboration for home-use vital signs monitoring. This
unique device will be the world’s first cloud-connected home-use BP monitor to include
ATCOR’s SphygmoCor® technology and Arty™, ATCOR’s new cardiovascular vital signs and
telehealth platform (Arty™ being an anagram of “Heart” and “Artery”).
The Agreement with Andon in conjunction with the ATCOR “Pulse” device significantly
expands the commercial market opportunity for CardieX into the home consumer health
device market, which is estimated to be worth $US2.5B annually (Source: Fortune Business
Insight).
When paired with ATCOR’s Arty™ app, the Device will provide full remote patient monitoring
of a patient’s vital signs at home. The remote patient monitoring market is estimated to
reach $US43B by 2027 (Source: 2020 Research & Markets Report).
At launch, the device and will also be fully telehealth-enabled with video, chat, messaging,
customizable screens and full vital signs sharing features between clinician and patient when
paired with the Company’s Arty™ app. ATCOR Pulse will be the first blood pressure device
ever to feature customizable screens and vital signs modules when integrated with the
Company’s new Arty™ app.
Add to My Watchlist
What is My Watchlist?
